Caitlin Firkin is the Business Development and Feasibility Manager for Momentum Clinical Research. She has 10 years of clinical research experience in both regulatory and business development roles. Her background includes roles within Roche and Novotech, giving her direct exposure to commercial, operational, and strategic requirements that shape clinical trial planning and delivery. This cross-sector experience provides her with a strong understanding of the clinical trial lifecycle, from early study evaluation and feasibility through to startup considerations, stakeholder management, and site execution requirements.
Her regulatory experience has given her a detailed understanding of the documentation, compliance, and governance requirements that support clinical research, while her business development background has focused on study opportunity assessment, client engagement, and network growth. Together, this experience enables her to assess opportunities not only from a commercial perspective, but also through the lens of protocol fit, site capability, startup complexity, and delivery risk. She has developed a practical understanding of the factors that influence study placement decisions, including patient population access, recruitment feasibility, competing trials, therapeutic alignment, and site resourcing.
In her current role, Caitlin leads the central feasibility process across Australia and New Zealand, managing study intake, protocol review, site identification, and network-level feasibility assessments. She works across internal teams, sponsors, and CRO partners to support high-quality feasibility submissions, consistent account management, and efficient pre-award coordination.